We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SON:NYSESonoco Products Company Analysis

Data as of 2026-09-01 - not real-time

$55.15

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Sonoco Products Company trades at $55.15, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 1.0%. RSI sits at 41.0, which reads as neutral, and MACD momentum is bearish. Watch $55.03 as support and $59.75 as the nearer resistance level.
On valuation the read is undervalued — an earnings multiple of 8.7, absent a reliable peer benchmark. Sell-side targets cluster 15.8% above the current quote. The 3.83% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 30.3%, a beta of 0.41 and a maximum drawdown of 19.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.

Top Market Events

HARTSVILLE, S.C., July 22, 2026 GLOBE NEWSWIRE -- Sonoco Products Company “Sonoco” or the “Company” NYSE: SON ,...HARTSVILLE, S.C., July 22, 2026 GLOBE NEWSWIRE -- Sonoco Products Company "Sonoco" or the "Company" NYSE: SON , a...HARTSVILLE, S.C., Aug. 04, 2026 GLOBE NEWSWIRE -- Sonoco Products Company “Sonoco” or the “Company” NYSE: SON ,...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 50.97
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 50.97
  • Analyst targets imply +15.8% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +15.8% versus the current price
  • Revenue contracting at -1.3%
  • P/E ratio of 8.7

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin8.41%
P/E Ratio8.7
ROE18.86%
ROA3.95%
Debt/Equity132.43
P/B Ratio1.5
Op. Cash Flow$637.1M
Free Cash Flow$527.1M

Technical Analysis

TrendBullish
RSI41.0
Support$55.03
Resistance$59.75
MA 20$57.67
MA 50$56.45
MA 200$50.97
MACDBearish
VolumeIncreasing
Fear & Greed Index93.23

Valuation

Fair Value$21.36
Target Price$63.89
Upside/Downside15.85%
GradeUndervalued
TypeValue
Dividend Yield3.83%

Risk Assessment

Beta0.41
Volatility30.32%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.